Skip to content

Zymeworks ZYME Income Taxes Paid, Net

Income Taxes Paid, Net at other companies

Pfizer logo
PfizerPFE
Charles River Laboratories logo
Charles River LaboratoriesCRL
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's income taxes paid, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's income taxes paid, net?
Zymeworks (ZYME) reported income taxes paid, net of $245K in Q1 2026.
How has Zymeworks's income taxes paid, net changed year-over-year?
Zymeworks's income taxes paid, net decreased by 36.7% year-over-year, from $387K to $245K.
What is the long-term trend for Zymeworks's income taxes paid, net?
Over 3 years (2022 to 2025), Zymeworks's income taxes paid, net has grown at a -48.7% compound annual growth rate (CAGR), from $10M to $1.35M.